Stuart Hawtin

1.4k total citations
36 papers, 1.1k citations indexed

About

Stuart Hawtin is a scholar working on Molecular Biology, Social Psychology and Endocrine and Autonomic Systems. According to data from OpenAlex, Stuart Hawtin has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Social Psychology and 10 papers in Endocrine and Autonomic Systems. Recurrent topics in Stuart Hawtin's work include Neuroendocrine regulation and behavior (21 papers), Receptor Mechanisms and Signaling (19 papers) and Circadian rhythm and melatonin (8 papers). Stuart Hawtin is often cited by papers focused on Neuroendocrine regulation and behavior (21 papers), Receptor Mechanisms and Signaling (19 papers) and Circadian rhythm and melatonin (8 papers). Stuart Hawtin collaborates with scholars based in United Kingdom, Switzerland and United States. Stuart Hawtin's co-authors include Mark S. Shearman, Mark Wheatley, Scott J. Pollack, Rosemary A. Parslow, Helen Howard, John Simms, Smita S. Patel, Andrew B. Tobin, Matthew T. Conner and Andrew R. Davies and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Stuart Hawtin

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Hawtin United Kingdom 20 724 294 274 259 138 36 1.1k
Joanne R. Mathiasen United States 19 643 0.9× 443 1.5× 231 0.8× 109 0.4× 93 0.7× 51 1.2k
Nathaniel G.N. Milton United Kingdom 20 466 0.6× 191 0.6× 349 1.3× 137 0.5× 75 0.5× 42 1.2k
Rita Raddatz United States 18 1.0k 1.4× 885 3.0× 179 0.7× 76 0.3× 142 1.0× 42 1.7k
Luís M. Orensanz Spain 21 309 0.4× 357 1.2× 209 0.8× 112 0.4× 169 1.2× 64 1.1k
Rajeshwar Narlawar Australia 16 289 0.4× 117 0.4× 163 0.6× 178 0.7× 82 0.6× 25 861
Yves Mérand Canada 24 545 0.8× 308 1.0× 106 0.4× 84 0.3× 130 0.9× 49 1.6k
Joel B. Yudkovitz United States 16 439 0.6× 175 0.6× 51 0.2× 152 0.6× 104 0.8× 22 1.3k
Ludo Kennis Belgium 7 537 0.7× 555 1.9× 169 0.6× 94 0.4× 62 0.4× 12 1.1k
Л. А. Андреева Russia 14 386 0.5× 283 1.0× 288 1.1× 45 0.2× 67 0.5× 198 881
Lawrence G. Iben United States 17 606 0.8× 686 2.3× 110 0.4× 54 0.2× 252 1.8× 34 1.1k

Countries citing papers authored by Stuart Hawtin

Since Specialization
Citations

This map shows the geographic impact of Stuart Hawtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hawtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hawtin more than expected).

Fields of papers citing papers by Stuart Hawtin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Hawtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hawtin. The network helps show where Stuart Hawtin may publish in the future.

Co-authorship network of co-authors of Stuart Hawtin

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Hawtin. A scholar is included among the top collaborators of Stuart Hawtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Hawtin. Stuart Hawtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giaglis, Stavros, André N. Tiaden, Anton Glück, et al.. (2025). A Cooperative Release of Mitochondrial DNA From Platelets and Neutrophils Drives an Interferon Signature in Systemic Sclerosis. Arthritis & Rheumatology.
2.
Révész, Láśzló, Achim Schlapbach, Reiner Aichholz, et al.. (2010). In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. Bioorganic & Medicinal Chemistry Letters. 20(15). 4715–4718. 23 indexed citations
3.
Velcicky, Juraj, Roland Feifel, Stuart Hawtin, et al.. (2009). Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy. Bioorganic & Medicinal Chemistry Letters. 20(3). 1293–1297. 35 indexed citations
4.
Schlapbach, Achim, Roland Feifel, Stuart Hawtin, et al.. (2008). Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity. Bioorganic & Medicinal Chemistry Letters. 18(23). 6142–6146. 35 indexed citations
5.
Conner, Matthew T., Stuart Hawtin, John Simms, et al.. (2007). Systematic Analysis of the Entire Second Extracellular Loop of the V1a Vasopressin Receptor. Journal of Biological Chemistry. 282(24). 17405–17412. 69 indexed citations
6.
Hawtin, Stuart, John Simms, Matthew T. Conner, et al.. (2006). Charged Extracellular Residues, Conserved throughout a G-protein-coupled Receptor Family, Are Required for Ligand Binding, Receptor Activation, and Cell-surface Expression. Journal of Biological Chemistry. 281(50). 38478–38488. 38 indexed citations
7.
Hawtin, Stuart. (2006). Pharmacological Chaperone Activity of SR49059 to Functionally Recover Misfolded Mutations of the Vasopressin V1a Receptor. Journal of Biological Chemistry. 281(21). 14604–14614. 34 indexed citations
9.
Hawtin, Stuart, Sookhee Ha, Douglas J. Pettibone, & Mark Wheatley. (2004). A Gly/Ala switch contributes to high affinity binding of benzoxazinone‐based non‐peptide oxytocin receptor antagonists. FEBS Letters. 579(2). 349–356. 11 indexed citations
10.
Hawtin, Stuart, John Simms, Rosemary A. Parslow, et al.. (2003). An arginyl in the N‐terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist. European Journal of Biochemistry. 270(23). 4681–4688. 8 indexed citations
13.
Bilmen, Jonathan G., et al.. (2002). Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium. 31(1). 45–52. 53 indexed citations
14.
Hawtin, Stuart, et al.. (2002). Agonist-Specific, High-Affinity Binding Epitopes Are Contributed by an Arginine in the N-Terminus of the Human Oxytocin Receptor. Biochemistry. 41(16). 5086–5092. 34 indexed citations
15.
Hawtin, Stuart, Andrew B. Tobin, Smita S. Patel, & Mark Wheatley. (2001). Palmitoylation of the Vasopressin V1a Receptor Reveals Different Conformational Requirements for Signaling, Agonist-induced Receptor Phosphorylation, and Sequestration. Journal of Biological Chemistry. 276(41). 38139–38146. 58 indexed citations
16.
Hawtin, Stuart, Andrew R. Davies, Glenn Matthews, & Mark Wheatley. (2001). Identification of the glycosylation sites utilized on the V1a vasopressin receptor and assessment of their role in receptor signalling and expression. Biochemical Journal. 357(1). 73–73. 7 indexed citations
17.
Wheatley, Mark, et al.. (1998). Structure/Function Studies on Receptors for Vasopressin and Oxytocin. Advances in experimental medicine and biology. 449. 363–365. 9 indexed citations
18.
Pollack, Scott J., et al.. (1995). Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells. Neuroscience Letters. 184(2). 113–116. 91 indexed citations
20.
Pollack, Scott J., et al.. (1995). Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion. Neuroscience Letters. 197(3). 211–214. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026